DiagnoCure (TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in making critical treatment decisions. DiagnoCure’s product offering is focused on molecular tests, which detect irregular gene or protein activity patterns associated with cancer.
Location: Canada, Quebec
Employees: 11-50
Founded date: 1994
Investors 1
| Date | Name | Website |
| - | Hub Angels... | hubangels.... |